Thermo Fisher Scientific Inc. (TMO) filed a Current Report on Form 8-K reporting that it announced financial results for its fiscal quarter ended June 27, 2026. The corporate action occurred on July 23, 2026, when Thermo Fisher issued a press release covering its quarterly results. The filing was made under Item 2.02, “Results of Operations and Financial Condition,” which companies use to furnish earnings releases and related financial information to the market. The press release itself is identified as Exhibit 99.1, dated July 23, 2026, and is incorporated by reference into the 8-K. The filing does not include the text of the earnings release in the provided document, so it does not disclose specific revenue, earnings, margin, guidance, cash flow, or segment-performance figures in the excerpt available here. It also does not report any insider transaction, securities issuance, share repurchase, dividend declaration, option grant, vesting event, or change in beneficial ownership. Accordingly, there are no transaction codes, share counts, exercise prices, sale prices, or post-transaction ownership figures to summarize. Thermo Fisher also included Item 9.01, “Financial Statements and Exhibits,” listing the July 23, 2026 press release as Exhibit 99.1 and an Inline XBRL cover page file as Exhibit 104. The company stated that the information in the report and its exhibits is being “furnished” rather than “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, meaning it is not automatically subject to certain liability provisions or incorporated into other Securities Act or Exchange Act filings unless specifically referenced. The report was signed on July 23, 2026, by Joseph R. Holmes, Thermo Fisher’s Vice President and Chief Accounting Officer. The filing matters because it formally notifies investors that Thermo Fisher released its quarterly financial results for the period ended June 27, 2026, even though the excerpt provided does not contain the detailed earnings numbers themselves.